In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 6, 2024, which could materially affect our business, financial condition or future results.
−Removed: Except as set forth below, there have been no material changes in our risk factors from those disclosed in that Annual Report.
−Removed: Our strategic growth plan, which involves the acquisition of other businesses, may not succeed.
−Removed: The Company's strategic growth plan calls for significant growth in its business over the next several years through an increase in its density in select markets where it is established as well as the expansion of its geographic footprint into new markets.
−Removed: This growth would place (and has placed) significant demands on the Company’s management team, systems, internal controls and financial and professional resources.
−Removed: As a result, the Company could be required to incur (and has incurred) expenses for hiring additional qualified personnel, retaining professionals to assist in developing the appropriate control systems and expanding the Company’s information technology infrastructure.
−Removed: If the Company is unable to effectively manage growth, its financial results could be adversely impacted.
−Removed: The Company’s strategic growth plan contemplates continued growth from future acquisitions of home medical equipment and service providers.
−Removed: The Company may face increased competition for attractive acquisition candidates, which may limit the number of acquisition opportunities available to the Company or lead to the payment of higher prices for its acquisitions.
−Removed: Without successful acquisitions, the Company’s future growth rate could decline.
−Removed: In addition, the Company cannot guarantee that any future acquisitions, if consummated, will result in further growth.
−Removed: The integration of acquisitions requires significant attention from management, may impose substantial demands on the Company’s operations or other projects and may impose challenges on us including, but not limited to, consistencies in business standards, procedures, policies and business cultures.
−Removed: There can be no assurance that any future acquisitions, if consummated, will result in further growth.
−Removed: Specific integration risks relating to the acquisition of other businesses by the Company may include:
−Removed: difficulties related to combining previously separate businesses into a single unit, including patient transitions, product and service offerings, distribution and operational capabilities and business cultures;
−Removed: availability of financing to the extent needed to fund acquisitions;customer loss and other general business disruption;
−Removed: managing the integration process while completing other independent acquisitions or dispositions;
−Removed: diversion of management’s attention from day-to-day operations;
−Removed: assumption of liabilities of an acquired business, including unforeseen or contingent liabilities or liabilities in excess of the amounts estimated;
−Removed: failure to realize anticipated benefits and synergies, such as cost savings and revenue enhancements;
−Removed: potentially substantial costs and expenses associated with acquisitions and dispositions;
−Removed: and failure to retain and motivate key employees difficulties in establishing and applying the Company’s internal control over financial reporting and disclosure controls and procedures to an acquired business.
−Removed: VIEMED HEALTHCARE, INC.
−Removed: September 30, 2023 and 2022
+Added: There have been no material changes in our risk factors from those disclosed in that Annual Report.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.